Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.91 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL5961178 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1940649 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL3899059 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL504068 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1431070 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1062721 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL848 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL5762 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL22768 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL116846 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 959 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630758-B2 | Downhole methods and compositions used in such | DORF KETAL CHEMICALS FZE (AE) | 2026-05-19 | — | — | US | claimed |
| EP-3589691-B1 | CABLE SHEATHING COMPOSITION | AEI COMPOUNDS LTD (GB) | 2026-01-14 | — | — | EP | claimed |
| US-20250388804-A1 | Acidizing Fluid with Foam Stabilizing Agent Comprising Antimony Compound | HALLIBURTON ENERGY SERVICES INC (US) | 2025-12-25 | — | — | US | claimed |
| US-12497557-B2 | Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing an acidic composition in the wellbore | DORF KETAL CHEMICALS FZE (AE) | 2025-12-16 | — | — | US | claimed |
| CN-120189936-A | Vanadium-chromium composite oxide material, preparation method and application | 中南民族大学 | 2025-06-24 | — | — | CN | claimed |
| CN-120189958-A | Vanadium-phosphorus composite oxide material, preparation method and application | 中南民族大学 | 2025-06-24 | — | — | CN | claimed |
| CN-120001397-A | Solid acid catalyst for synthesizing adamantane and synthesis and application thereof | 中国科学院大连化学物理研究所 | 2025-05-16 | — | — | CN | claimed |
| CN-119701990-A | Composite oxide catalyst and synthesis and application thereof in synthesizing methacrylonitrile | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-116273099-B | Silicon-aluminum composite oxide carrier supported catalyst and preparation method and application thereof | 中南民族大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119343021-A | Perovskite solar cell, preparation method thereof and photovoltaic system | 天合光能股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-85106854-A | The preparation of ferromagnetic chromium dioxide | — | 1987-02-25 | — | — | CN | claimed |
| EP-0085562-B1 | CORROSION INHIBITOR COMPRISING SB AND MO SALTS AND PROCESS FOR INHIBITING CORROSION USING THE INHIBITOR | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-05-21 | — | — | EP | claimed |
| EP-0169651-A2 | Method and composition for protecting metal surfaces from oxidative environments | HALLIBURTON COMPANY (US) | 1986-01-29 | — | — | EP | claimed |
| US-4566953-A | Pulse plating of nickel-antimony films | AT&T TECHNOLOGIES, INC. (US) | 1986-01-28 | — | — | US | claimed |
| US-4522658-A | COATING WITH ACETYLENIC ALCOHOL, QUARTERNARY AMMONIUM COMPOUND, HYDROCARBON, AND ANTIMONY COMPOUND | HALLIBURTON COMPANY (US) | 1985-06-11 | — | — | US | claimed |
| US-4498997-A | MIXTURE OF ACETYLENIC ALCOHOL, QUATERNARY AMMONIUM COMPOUND, AROMATIC HYDROCARBON AND ANTIMONY COMPOUND | HALLIBURTON COMPANY (US) | 1985-02-12 | — | — | US | claimed |
| EP-0130006-A1 | Method and composition for reducing the corrosivity of acids to ferrous metals | HALLIBURTON COMPANY (US) | 1985-01-02 | — | — | EP | claimed |
| US-4143186-A | ON A HIGH TEMPERATURE POLYMER; DIMETHYLAMINE BORANE AS REDUCING AGENT, COMPLEXING AGENT | AMP INCORPORATED (US) | 1979-03-06 | — | — | US | claimed |
| US-4092355-A | ACROLEIN, METHACROLEIN | ATLANTIC RICHFIELD COMPANY (US) | 1978-05-30 | — | — | US | claimed |
| US-4033415-A | CROSSLINKED AQUEOUS GEL | HALLIBURTON COMPANY (US) | 1977-07-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630758-B2 | Downhole methods and compositions used in such | IL1B, GET3, IL17A | TSHR 4125/4885TP53 1603/4885CYP2C9 3225/4885 |
| US-20250388804-A1 | Acidizing Fluid with Foam Stabilizing Agent Comprising Antimony Compound | FIBP, DSTN, SUCLG1 | TSHR 3938/4885TP53 429/4885CYP2C9 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.